Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
bioMerieux ( (FR:BIM) ) just unveiled an update.
bioMérieux has announced the availability of documents related to its upcoming Combined General Meeting scheduled for May 15, 2025. Shareholders are informed about the procedures to access these documents, which are crucial for understanding the agenda and resolutions to be discussed at the meeting.
More about bioMerieux
YTD Price Performance: 10.14%
Average Trading Volume: 48,810
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €13.22B
For a thorough assessment of BIM stock, go to TipRanks’ Stock Analysis page.